Effects of two differently heparin-coated extracorporeal circuits on markers for brain and myocardial dysfunction

Perfusion

Volumn 17, Issue 5, 2002, Pages 339-345

  Flom Halvorsen, Hanne I ^a   Ovrum E ^a   Brosstad, F ^a   Tangen, G ^a   Ringdal, M A L ^a   Oystese R ^a  

^a Oslo Heart Center   (Norway)

Author keywords

[No Author keywords available]

Indexed keywords

CREATINE KINASE MB; DIAZEPAM; FENTANYL; HEPARIN; ISOFLURANE; MIDAZOLAM; MYOGLOBIN; NEURON SPECIFIC ENOLASE; NITROUS OXIDE; PANCURONIUM BROMIDE; PROTEIN S100B; TROPONIN I; BIOLOGICAL MARKER; BIOMATERIAL; CREATINE KINASE; ENOLASE; NERVE GROWTH FACTOR; PROTEIN S 100; S 100 CALCIUM BINDING PROTEIN BETA SUBUNIT; S-100 CALCIUM-BINDING PROTEIN BETA SUBUNIT;

ADULT; AGED; ARTICLE; BRAIN DYSFUNCTION; CARDIOPULMONARY BYPASS; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORONARY ARTERY BYPASS GRAFT; CORRELATION ANALYSIS; DISEASE MARKER; ELECTIVE SURGERY; ENZYME BLOOD LEVEL; EQUIPMENT; EXTRACORPOREAL CIRCULATION; FEMALE; HEPARINIZATION; HUMAN; INTERMETHOD COMPARISON; MALE; MYOCARDIAL DISEASE; PRIORITY JOURNAL; PROSPECTIVE STUDY; PROTEIN BLOOD LEVEL; RANDOMIZED CONTROLLED TRIAL; STATISTICAL SIGNIFICANCE; BLOOD; BRAIN DISEASE; CARDIOMYOPATHY; COMPARATIVE STUDY; INSTRUMENTATION; MIDDLE AGED;

AGED; BIOLOGICAL MARKERS; BRAIN DISEASES; CARDIOMYOPATHIES; CARDIOPULMONARY BYPASS; COATED MATERIALS, BIOCOMPATIBLE; CREATINE KINASE; FEMALE; HEPARIN; HUMANS; MALE; MIDDLE AGED; MYOGLOBIN; NERVE GROWTH FACTORS; PHOSPHOPYRUVATE HYDRATASE; S100 PROTEINS; TROPONIN I;

EID: 0036376782     PISSN: 02676591     EISSN: None     Source Type: Journal    
DOI: 10.1191/0267659102pf594oa     Document Type: Article

References (28)

1. Complement and the damaging effects of cardiopulmonary bypass
2. Heparin-coated circuits reduce the inflammatory response to cardiopulmonary bypass
3. Heparin-coated bypass circuits reduce pulmonary injury
4. Complement and granulocyte activation in two different types of heparinized extracorporeal circuits
5. Disparity in blood activation by two different heparin-coated cardiopulmonary bypass systems
6. Endothelin-1 and neutrophil activation during heparin-coated cardiopulmonary bypass
7. Consistent non-pharmacologic blood conservation in primary and reoperative coronary artery bypass grafting
8. Comparison of two heparin-coated extracorporeal circuits with reduced systemic anticoagulation in routine coronary artery bypass surgery
9. Time course of neurone-specific enolase and S-100 protein release during and after coronary artery bypass grafting
10. Release of S-100B during coronary artery bypass grafting is reduced by off-pump surgery
11. Serum S-100 protein concentration after cardiac surgery: A randomized trial of arterial line filtration
12. Clinical effects of the heparin coated surface in cardiopulmonary bypass
13. Intraoperative embolus formation during cardiopulmonary bypass affects the release of S-100B
14. Is there a relationship between serum S-100β protein and neuropsychologic dysfunction after cardiopulmonary bypass?
15. Neurobehavioral outcome prediction after cardiac surgery: Role of neurobiochemical markers of damage to neuronal and glial brain tissue
16. Serum and CSF levels of neuron-specific enolase (NSE) in cardiac surgery with cardiopulmonary bypass: A marker of brain injury?
17. The effect of cardiotomy suction on the brain injury marker S100β after cardiopulmonary bypass
18. S-100Beta after coronary artery surgery: Release pattern, source of contamination, and relation to neuropsychological outcome
19. S-100B as a predictor of size and outcome of stroke after cardiac surgery
20. Increase in serum S100A1-B and S100BB during cardiac surgery arises from extracerebral sources
21. Cardiotomy suction: A major source of brain lipid emboli during cardiopulmonary bypass
22. Autotransfusion in coronary artery bypass grafting: Disparity in laboratory tests and clinical performance
23. Impact of transfusion of mediastinal shed blood on serum levels of cardiac enzymes
24. Serum enzymes with special reference to CK-MB following coronary bypass surgery
25. Avoiding cardiopulmonary bypass in multivessel CABG reduces cytokine response and myocardial injury
26. Heparin-coated circuits reduce myocardial injury in heart or heart-lung transplantation: A prospective, randomized study
27. Heparin-bonded circuits decrease myocardial ischemic damage: An experimental study
28. Total complement inhibition: An effective strategy to limit ischemic injury during coronary revascularization on cardiopulmonary bypass